Your browser doesn't support javascript.
loading
Epidemiology of Japanese encephalitis in the Philippines prior to routine immunization.
Lopez, Anna Lena; Raguindin, Peter Francis; Aldaba, Josephine G; Avelino, Ferchito; Sy, Ava Kristy; Heffelfinger, James D; Silva, Maria Wilda T.
Afiliação
  • Lopez AL; Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines Manila, Manila, Philippines.
  • Raguindin PF; Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines Manila, Manila, Philippines; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland. Electronic address: peter.raguindin@ispm.unibe.ch.
  • Aldaba JG; Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines Manila, Manila, Philippines.
  • Avelino F; Department of Health, Manila, Philippines.
  • Sy AK; Research Institute for Tropical Medicine, Manila, Philippines.
  • Heffelfinger JD; World Health Organization Regional Office for the Western Pacific, Manila, Philippines.
  • Silva MWT; Department of Health, Manila, Philippines.
Int J Infect Dis ; 102: 344-351, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33127505
ABSTRACT

BACKGROUND:

Findings were published in 2015 that highlighted the endemicity of Japanese Encephalitis (JE) in the Philippines. The policymakers responded by conducting an immunization campaign and strengthening the surveillance system. Using data on the revitalized surveillance system, the epidemiology of JE in the country was updated.

METHODS:

Electronic databases were searched, and conference proceedings related to JE in the Philippines were identified until 31 December 2018. Surveillance data from 01 January 2014 to 31 December 2017 were used. The 2015 population census was used to estimate the national and regional incidence for children aged <15 years.

RESULTS:

Four studies reported the seroprevalence of JE in the Philippines, which showed increasing seroprevalence with increasing age. Seroprevalence rates were from 0% for infants (aged <1 year) to 65.7% in adolescents (12-18 years) before the immunization campaign. Among five studies on the clinical profile of JE, case fatality ranged from 0 to 21.1% and neurologic sequelae ranged from 5.2 to 81.8% of diagnosed cases. In the surveillance data, JE cases peaked annually from July to October, coinciding with the wet season. The national incidence was estimated at a minimum of 0.7 JE cases/100,000 among children aged <15 years, but higher rates were seen in the northern regions of the country.

CONCLUSION:

Improved surveillance affirmed the burden of JE in the Philippines. A subnational immunization campaign in April 2019 was conducted in the northern regions of the country. This paper highlights the importance of including the JE vaccine in the immunization program and sustained high-quality surveillance to monitor its impact on JE control.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Programas de Imunização / Encefalite Japonesa / Vacinas contra Encefalite Japonesa Tipo de estudo: Incidence_studies / Prognostic_studies / Screening_studies / Systematic_reviews Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Programas de Imunização / Encefalite Japonesa / Vacinas contra Encefalite Japonesa Tipo de estudo: Incidence_studies / Prognostic_studies / Screening_studies / Systematic_reviews Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article